Substituted N-(1H-indazol-4-yl)imidazo[1, 2-a]pyridine-3- carboxamide compounds as cFMS inhibitors

Details for Australian Patent Application No. 2010333752 (hide)

Owner Array BioPharma Inc.

Inventors Boys, Mark Laurence; Bradley, Michael F.; Delisle, Robert Kirk; Hennings, D. David; Kennedy, April L.; Marmsater, Fredrik P.; Medina, Matthew David; Munson, Mark C.; Rast, Bryson; Rizzi, James P.; Rodriguez, Martha E.; Topalov, George T.; Zhao, Qian

Agent Pizzeys

Pub. Number AU-A-2010333752

PCT Pub. Number WO2011/079076

Priority 61/288,729 21.12.09 US

Filing date 20 December 2010

Wipo publication date 30 June 2011

International Classifications

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437

A61K 31/4985 - Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems

A61P 9/00 Drugs for disorders of the cardiovascular system

A61P 19/08 Drugs for skeletal disorders

A61P 29/00 Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 Antineoplastic agents

C07D 519/00 Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or

Event Publications

9 August 2012 PCT application entered the National Phase

  PCT publication WO2011/079076 Priority application(s): WO2011/079076

6 September 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 20 Jul 2012

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010333753-Furin-knockdown and GM-CSF-augmented (FANG) cancer vaccine

2010333751-Method of treating and/or preventing conditions caused by microorganisms using an oral light device